Home Featured Page 2

Featured

Latest

Psychedelic Bulletin: Microdosing Study Causes a Stir; COMPASS Secures 5th US Patent; Leave Toads Alone?

Numinus Receives Conditional Approval to Graduate to the Toronto Stock Exchange

Numinus Announces Departure of Stacey Wallin

PTSF86 – Ayahuasca, Chronic Pain, and Legal Psilocybin, with Payton Nyquvest of Numinus

Seelos Therapeutics Raises $20 Million in Private Placement of Senior Secured Convertible Note

Numinus to Begin Trading on the OTC Under Symbol NUMIF

Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study...

PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid...

Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human...

Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test

Small Pharma Strengthens Board With Appointment of Paul Maier as Independent...

Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for...

Eyes on Oregon, a Psychedelics Today Podcast with Jon Dennis and...

Filament Health Announces Co-Development and Exclusive Licensing Agreement with Entheotech Bioscience

123...100 Page 2 of 100

EDITOR PICKS

Psychedelic Bulletin: Microdosing Study Causes a Stir; COMPASS Secures 5th US...

Numinus Receives Conditional Approval to Graduate to the Toronto Stock Exchange

Numinus Announces Departure of Stacey Wallin

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

PTSF49 – MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians

Psychedelic Bulletin: Field Trip Raising $83m; NYU Langone Launches Psychedelic Medicine...

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelic Bulletin: Microdosing Study Causes a Stir; COMPASS Secures 5th US Patent; Leave Toads Alone?

Numinus Receives Conditional Approval to Graduate to the Toronto Stock Exchange

Numinus Announces Departure of Stacey Wallin

PTSF86 – Ayahuasca, Chronic Pain, and Legal Psilocybin, with Payton Nyquvest of Numinus

Seelos Therapeutics Raises $20 Million in Private Placement of Senior Secured Convertible Note

Numinus to Begin Trading on the OTC Under Symbol NUMIF

Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study...

PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid...

Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human...

Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test

Small Pharma Strengthens Board With Appointment of Paul Maier as Independent...

Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for...

Eyes on Oregon, a Psychedelics Today Podcast with Jon Dennis and...

Filament Health Announces Co-Development and Exclusive Licensing Agreement with Entheotech Bioscience

EDITOR PICKS

Psychedelic Bulletin: Microdosing Study Causes a Stir; COMPASS Secures 5th US...

Numinus Receives Conditional Approval to Graduate to the Toronto Stock Exchange

Numinus Announces Departure of Stacey Wallin

POPULAR POSTS

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

PTSF49 – MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians

Psychedelic Bulletin: Field Trip Raising $83m; NYU Langone Launches Psychedelic Medicine...

POPULAR CATEGORY